FIELD: organic chemistry, chemical technology, medicine, pharmacy.
SUBSTANCE: invention relates to new 1-{N-[2-(diethylamino)ethyl]-N-[4-(4-trifluoromethylphenyl)-benzyl]aminocarbonylmethyl}-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidine-4-one of the formula (I):
or its pharmaceutically acceptable salt that elicit properties of inhibitor of enzyme Lp-PLA2 and can be used for treatment or prophylaxis of morbidity state associated with activity of indicated enzyme. Such disease can be atherosclerosis and also diabetes, hypertension, stenocardia, reprefusion, ischemia, rheumatoid arthritis, Alzheimer's disease, myocardium infarction, sepsis, acute and chronic inflammation and psoriasis. Compounds can be used, in particular, for preparing a medicinal agent used for primary and secondary prophylaxis of acute coronary attacks. Compound of the formula (I) is prepared by interaction of compound of the formula (II):
with compound of the formula (III): 
under conditions of amide formation. Invention relates also to a pharmaceutical composition.
EFFECT: improved preparing method, valuable medicinal properties of compound.
20 cl, 1 sch, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
| NOVEL SUBSTITUTED INDOLES | 2003 |
|
RU2288914C2 |
| OBTAINING AND USING TRICYCLIC PYRIMIDINONE COMPOUND AND COMPOSITION THEREOF | 2021 |
|
RU2820903C1 |
| INDOLE DERIVATIVES, THEIR OPTICAL ISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS | 1991 |
|
RU2095360C1 |
| SULFONAMIDE GROUPS-CONTAINING HETEROCYCLIC COMPOUND, INTERMEDIATE COMPOUND AND ANTI-ANGIOGENIC AGENT BASED ON THEREOF | 2000 |
|
RU2239631C2 |
| DERIVATIVES OF (AZETHIDINE-1-YLALKYL)-LACTAMES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT OF HUMANS WHEN PATIENTS ARE TREATED BY PRODUCING ANTAGONISTIC EFFECT ON TACHYKININ ACTING IN HUMAN NK-, NK- AND NK-RECEPTORS OR IN THEIR COMBINATION | 1995 |
|
RU2150468C1 |
| INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2288228C2 |
| NEW PYRROLO[3,2-d]PYRIMIDIN-4-ONE DERIVATIVES AND USING THEM IN THERAPY | 2005 |
|
RU2577858C2 |
| PYRAZINONE DERIVATIVES AND USE THEREOF IN TREATMENT OF LUNG DISEASES | 2008 |
|
RU2479580C2 |
| C-4 CARBONATE-COMPRISING TAXANES | 2000 |
|
RU2243223C2 |
